You May Also Like

Reply to drs. Angulo and collignon
Cite
CITE Title : Reply to drs. Angulo and collignon Personal Author(s) : Davis, MA;Hancock, DD;Besser, TE;Rice, DH;Gay, JM; Published Date : Jul 2000 Source : Emerg Infect Dis. 6(4):437-438. URL : https://stacks.cdc.gov/view/cdc/15011
• File Format:
Copy Export
• RIS
[PDF - 41.14 KB]
Personal Author:
Davis, MA ;
Hancock, DD
...
Jul 2000 | Emerg Infect Dis. 6(4):437-438.
No Description
File Type:
[PDF - 41.14 KB]
File Type:
[PDF - 41.14 KB]

Using Reduced Inoculum Densities of Mycobacterium tuberculosis in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation
Cite
CITE Title : Using Reduced Inoculum Densities of Mycobacterium tuberculosis in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation Personal Author(s) : Morlock, Glenn P.;Tyrrell, Frances C.;Baynham, Dorothy;Escuyer, Vincent E.;Green, Nicole;Kim, Youngmi;Longley-Olson, Patricia A.;Parrish, Nicole;Pennington, Courtney;Tan, Desmond;Austin, Brett;Posey, James E.; Published Date : 2017;2017; Source : Tuberc Res Treat. 2017; 2017 URL : https://stacks.cdc.gov/view/cdc/121645
• File Format:
Copy Export
• RIS
[PDF - 739.94 KB]
Personal Author:
Morlock, Glenn P. ;
Tyrrell, Frances C.
...
2017 | Tuberc Res Treat. 2017; 2017
Description:
The primary platform used for pyrazinamide (PZA) susceptibility testing of | is the MGIT culture system (Becton Dickinson). Since false-resistant resu...
File Type:
[PDF - 739.94 KB]
File Type:
[PDF - 739.94 KB]